Biora Therapeutics, Inc. (BIOR) Misses Q1 EPS by 152c

Biora Therapeutics, Inc. (NASDAQ: BIOR) reported Q1 EPS of ($1.59), $1.52 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Biora Therapeutics, Inc. (BIOR) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'